Harmony Biosciences Holdings (HRMY) Shares Outstanding (2019 - 2026)

Harmony Biosciences Holdings has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $57.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 0.83% year-over-year to $57.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.9 million (up 0.83% YoY) and the FY2025 annual result came in at $57.7 million, up 1.02% from the prior year.
• Shares Outstanding (Entity) was little changed at $57.9 million in Q1 2026 per HRMY's latest filing, from $57.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $60.0 million in Q2 2023 and troughed at $56.8 million in Q4 2023.
• A 5-year average of $58.1 million and a median of $57.7 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) increased 3.76% in 2022, then retreated 5.28% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $59.6 million in 2022, then dropped by 4.77% to $56.8 million in 2023, then rose by 0.66% to $57.1 million in 2024, then climbed by 1.02% to $57.7 million in 2025, then rose by 0.24% to $57.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $57.9 million, $57.7 million, and $57.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.